Pila Pharma AB Income Statement

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2020 - 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2020 - 2016
Operating Revenue	1.13	0.77	1.46	1.88	0.72	Upgrade
Other Revenue	-	0.02	-	-	-	Upgrade
Revenue	1.13	0.79	1.46	1.88	0.72	Upgrade
Revenue Growth (YoY)	42.68%	-46.01%	-22.21%	161.49%	-	Upgrade
Cost of Revenue	6.95	6.69	3.33	-	0.04	Upgrade
Gross Profit	-5.82	-5.9	-1.87	1.88	0.68	Upgrade
Selling, General & Admin	1	1.13	3.45	10.75	9.91	Upgrade
Other Operating Expenses	-	-	-	0	0.01	Upgrade
Operating Expenses	2.08	2.21	4.52	10.77	9.94	Upgrade
Operating Income	-7.89	-8.11	-6.39	-8.89	-9.26	Upgrade
Interest Expense	-0.22	-0	-0.04	-0	-0.03	Upgrade
Currency Exchange Gain (Loss)	-	-0.05	-	-	-	Upgrade
Other Non Operating Income (Expenses)	-8.75	-3.08	-3.5	-17.89	-7.92	Upgrade
Pretax Income	-16.86	-11.24	-9.93	-26.78	-17.21	Upgrade
Net Income	-16.86	-11.24	-9.93	-26.78	-17.21	Upgrade
Net Income to Common	-16.86	-11.24	-9.93	-26.78	-17.21	Upgrade
Shares Outstanding (Basic)	35	25	21	17	13	Upgrade
Shares Outstanding (Diluted)	35	25	21	17	13	Upgrade
Shares Change (YoY)	35.92%	20.66%	22.29%	31.86%	30.89%	Upgrade
EPS (Basic)	-0.49	-0.44	-0.47	-1.55	-1.32	Upgrade
EPS (Diluted)	-0.62	-0.44	-0.47	-1.55	-1.32	Upgrade
Gross Margin	-	-	-127.74%	100.00%	94.68%	Upgrade
Operating Margin	-700.44%	-1026.62%	-436.99%	-472.69%	-1287.57%	Upgrade
Profit Margin	-1496.27%	-1423.15%	-678.73%	-1423.73%	-2392.46%	Upgrade
EBITDA	-6.82	-7.03	-5.32	-8.87	-9.24	Upgrade
D&A For EBITDA	1.08	1.08	1.08	0.02	0.02	Upgrade
EBIT	-7.89	-8.11	-6.39	-8.89	-9.26	Upgrade
Revenue as Reported	1.13	0.79	1.46	1.88	0.72	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.